Concepedia

Robert Schoenleber

RS

21

Publications

2K

Citations

17

H-Index

1983

Active since

Affiliations

Bayer (United States)(Current)

Bayer (Germany)

Abbott Fund

Abbott (United States)

Abbott (United Kingdom)

Robert Schoenleber is an author at Bayer (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1983–2007

21

Publications

21

Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo

Jacqueline W. Pierce, Robert Schoenleber, Gary Jesmok et al. · Journal of Biological Chemistry · 1997 · 1.1K citations · Full text

Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity

Joachim Rudolph, William P. Esler, Stephen O’Connor et al. · Journal of Medicinal Chemistry · 2007 · 157 citations · Full text

, , +17

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

John W. Kebabian, Donald R. Britton, Michael P. DeNinno et al. · European Journal of Pharmacology · 1992 · 156 citations

, , +8

A68930: a potent agonist selective for the dopamine D1 receptor

Michael P. DeNinno, Robert Schoenleber, Robert G. MacKenzie et al. · European Journal of Pharmacology · 1991 · 88 citations

, , +9

Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor

Michael P. DeNinno, Robert Schoenleber, Richard J. Perner et al. · Journal of Medicinal Chemistry · 1991 · 63 citations · Full text

Rows per page

1–5 of 21